PriceTargets.com logo

Livent - LTHM Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $16.67
  • Forecasted Upside: 0.95%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$16.51 As of 01/4/2024 01:00 AM ET
+0 (0.00%)
Get New Livent Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LTHM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LTHM

Analyst Price Target is $16.67
▲ +0.95% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Livent in the last 3 months. The average price target is $16.67, with a high forecast of $20.00 and a low forecast of $15.00. The average price target represents a 0.95% upside from the last price of $16.51.

This chart shows the closing price for LTHM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 3 contributing investment analysts is to reduce stock in Livent. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/28/2023MizuhoBoost TargetNeutral ➝ Neutral$15.00 ➝ $20.00
12/5/2023Piper SandlerDowngradeNeutral ➝ Underweight$18.00 ➝ $15.00
11/29/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$25.00 ➝ $15.00
11/1/2023BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$24.00 ➝ $20.00
11/1/2023KeyCorpLower TargetOverweight ➝ Overweight$32.00 ➝ $29.00
10/25/2023Piper SandlerDowngradeOverweight ➝ Neutral$33.00 ➝ $19.00
10/25/2023Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$27.00 ➝ $21.00
10/3/2023KeyCorpLower TargetOverweight ➝ Overweight$34.00 ➝ $32.00
9/1/2023Piper SandlerLower TargetOverweight ➝ Overweight$38.00 ➝ $33.00
8/4/2023KeyCorpLower TargetOverweight ➝ Overweight$35.00 ➝ $34.00
7/11/2023KeyCorpBoost Target$32.00 ➝ $35.00
6/23/2023HSBCLower Target$37.00 ➝ $33.50
5/11/2023B. RileyUpgradeNeutral ➝ Buy$32.00
5/4/2023CICC ResearchUpgradeMarket Perform ➝ Outperform
5/4/2023MizuhoLower Target$30.00 ➝ $29.00
4/20/2023Deutsche Bank AktiengesellschaftBoost TargetHold$23.00 ➝ $25.00
4/5/2023Raymond JamesLower TargetOutperform$35.00 ➝ $30.00
4/5/2023Bank of AmericaUpgradeNeutral ➝ Buy$29.00 ➝ $27.00
2/16/2023CitigroupBoost TargetNeutral$27.00 ➝ $28.00
2/16/2023MizuhoBoost TargetNeutral$27.00 ➝ $30.00
2/16/2023Bank of AmericaDowngradeBuy ➝ Neutral$26.00 ➝ $29.00
2/15/2023ScotiabankReiterated RatingSector Perform
1/12/2023MizuhoLower TargetNeutral$31.00 ➝ $27.00
1/11/2023Bank of AmericaUpgradeUnderperform ➝ Buy$27.00 ➝ $26.00
1/10/2023Deutsche Bank AktiengesellschaftLower Target$30.00 ➝ $22.00
1/4/2023Vertical ResearchUpgradeHold ➝ Buy$30.00
12/15/2022CitigroupLower Target$31.00 ➝ $27.00
12/15/2022Piper SandlerLower TargetOverweight$42.00 ➝ $38.00
10/27/2022B. RileyBoost TargetNeutral$30.00 ➝ $32.00
10/17/2022JPMorgan Chase & Co.Initiated CoverageNeutral$28.00
10/13/2022Raymond JamesBoost TargetOutperform$33.00 ➝ $35.00
10/4/2022CitigroupBoost Target$27.00 ➝ $32.00
10/4/2022Deutsche Bank AktiengesellschaftBoost Target$26.00 ➝ $27.00
10/3/2022Bank of AmericaDowngradeNeutral ➝ Underperform$31.00 ➝ $27.00
9/20/2022Piper SandlerReiterated RatingOverweight$42.00
9/12/2022Vertical ResearchDowngradeBuy ➝ Hold$33.00 ➝ $35.00
8/9/2022CitigroupBoost Target$27.00
8/8/2022CICC ResearchInitiated CoverageOutperform$27.30
8/4/2022MizuhoLower TargetNeutral$34.00 ➝ $30.00
7/6/2022Deutsche Bank AktiengesellschaftLower TargetHold$29.00 ➝ $24.00
5/17/2022Deutsche Bank AktiengesellschaftInitiated CoverageHold$29.00
5/5/2022MizuhoBoost Target$26.00 ➝ $34.00
5/4/2022CowenUpgradeMarket Perform ➝ Outperform
5/4/2022CowenUpgradeMarket Perform ➝ Outperform$25.00 ➝ $33.00
3/1/2022The Goldman Sachs GroupLower TargetSell$23.00 ➝ $20.00
2/23/2022MizuhoLower TargetNeutral$31.00 ➝ $26.00
2/1/2022Bank of AmericaUpgradeUnderperform ➝ Neutral
1/11/2022Piper SandlerLower Target$34.00 ➝ $31.00
1/4/2022Vertical ResearchUpgradeHold ➝ Buy$30.00
12/15/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$22.00 ➝ $23.00
11/19/2021Evercore ISIReiterated RatingBuy$40.00
11/9/2021MizuhoBoost TargetNeutral$26.00 ➝ $31.00
11/9/2021CitigroupDowngradeBuy ➝ Neutral$31.00
11/5/2021Raymond JamesBoost TargetOutperform$26.00 ➝ $33.00
10/12/2021MizuhoInitiated CoverageNeutral$26.00
10/12/2021CitigroupUpgradeNeutral ➝ Buy$25.00 ➝ $28.00
10/5/2021Raymond JamesBoost TargetOutperform$24.00 ➝ $26.00
10/4/2021Loop CapitalBoost TargetBuy$27.00 ➝ $28.00
10/1/2021Piper SandlerInitiated CoverageOverweight$29.00
8/30/2021CowenBoost TargetOutperform$19.00 ➝ $25.00
8/23/2021Loop CapitalBoost TargetBuy$24.00 ➝ $27.00
8/11/2021Bank of AmericaBoost TargetUnderperform$18.00 ➝ $19.00
8/9/2021CitigroupBoost TargetNeutral$22.00 ➝ $25.00
8/9/2021Vertical ResearchUpgradeSell ➝ Hold$22.00
4/19/2021Evercore ISIUpgradeIn-Line ➝ Outperform$20.00 ➝ $22.00
3/15/2021Credit Suisse GroupReiterated RatingNeutral$14.00
3/10/2021CowenInitiated CoverageMarket Perform$19.00
3/5/2021B. RileyInitiated CoverageNeutral$19.00
2/23/2021Credit Suisse GroupBoost TargetNeutral$12.00 ➝ $14.00
2/22/2021ArgusUpgradeHold ➝ Buy$23.00
1/8/2021Raymond JamesDowngradeStrong-Buy ➝ Outperform$18.00 ➝ $24.00
1/6/2021Smith Barney CitigroupDowngradeBuy ➝ Neutral
1/5/2021Evercore ISIBoost Target$10.00 ➝ $20.00
12/9/2020Loop CapitalBoost TargetBuy$13.00 ➝ $21.00
12/7/2020Raymond JamesBoost TargetStrong-Buy$14.00 ➝ $18.00
11/9/2020Smith Barney CitigroupUpgradeNeutral ➝ Buy$12.50 ➝ $16.50
11/9/2020Vertical ResearchDowngradeHold ➝ Sell
11/6/2020BMO Capital MarketsBoost TargetMarket Perform$8.50 ➝ $9.00
10/8/2020Raymond JamesBoost TargetStrong-Buy$9.00 ➝ $14.00
9/22/2020Evercore ISIInitiated Coverage$10.00
8/25/2020Raymond JamesInitiated CoverageStrong-Buy$9.00
8/10/2020CitigroupBoost TargetNeutral$7.00 ➝ $7.50
8/4/2020Credit Suisse GroupReiterated RatingHold$5.00
7/2/2020Loop CapitalLower TargetPositive ➝ Buy$10.00 ➝ $8.00
5/12/2020BMO Capital MarketsBoost TargetMarket Perform$5.50 ➝ $6.50
5/12/2020Credit Suisse GroupLower TargetNeutral$6.00 ➝ $5.00
4/9/2020CitigroupLower TargetNeutral$9.00 ➝ $6.00
4/6/2020BMO Capital MarketsDowngradeMarket Perform ➝ Underperform
4/5/2020BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$7.50 ➝ $5.50
3/30/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$9.50 ➝ $5.00
3/26/2020Vertical ResearchUpgradeSell ➝ Hold
3/25/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight
2/21/2020Vertical ResearchDowngradeHold ➝ Sell
2/21/2020BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$7.50
2/18/2020Credit Suisse GroupDowngradeOutperform ➝ Neutral$9.00 ➝ $11.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Livent logo
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was founded in 1940 and is headquartered in Philadelphia, Pennsylvania.
Read More

Today's Range

Now: $16.51
Low: $16.51
High: $16.51

50 Day Range

MA: $16.24
Low: $13.04
High: $18.55

52 Week Range

Now: $16.51
Low: $12.76
High: $29.17

Volume

N/A

Average Volume

29,534,803 shs

Market Capitalization

$2.97 billion

P/E Ratio

9.22

Dividend Yield

N/A

Beta

1.76

Frequently Asked Questions

What sell-side analysts currently cover shares of Livent?

The following equities research analysts have issued reports on Livent in the last year: JPMorgan Chase & Co., Mizuho, and Piper Sandler.
View the latest analyst ratings for LTHM.

What is the current price target for Livent?

0 Wall Street analysts have set twelve-month price targets for Livent in the last year. Their average twelve-month price target is $16.67, suggesting a possible upside of 0.9%. Mizuho has the highest price target set, predicting LTHM will reach $20.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $15.00 for Livent in the next year.
View the latest price targets for LTHM.

What is the current consensus analyst rating for Livent?

Livent currently has 1 sell rating and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for LTHM.

What other companies compete with Livent?

Other companies that are similar to Livent include FMC, Balchem, Olin, Ashland and Huntsman. Learn More about companies similar to Livent.

How do I contact Livent's investor relations team?

Livent's physical mailing address is 2929 WALNUT STREET, PHILADELPHIA PA, 19104. The company's listed phone number is (215) 299-5900 and its investor relations email address is [email protected]. The official website for Livent is www.livent.com. Learn More about contacing Livent investor relations.